Recruiting soon

Lifeline Ductus Arteriosus Stent for Ductal Patency

0 criteria met from your profileSee at a glance how your profile meets each eligibility criteria.
What is being tested

Ductus Arteriosus Stent

Device
Who is being recruted

Congenital Abnormalities+3

+ Cardiovascular Diseases

+ Heart Defects, Congenital

Until 6 Months
+24 Eligibility Criteria
See all eligibility criteria
How is the trial designed

Treatment Study

Interventional
Study Start: October 2025
See protocol details

Summary

Principal SponsorStarlight Cardiovascular Inc
Study ContactMary Beth Tate, BSBE-MBA
Last updated: January 28, 2026
Sourced from a government-validated database.Claim as a partner

Study start date: October 1, 2025

Actual date on which the first participant was enrolled.

This study is being conducted to evaluate a medical device called the Lifeline Ductus Arteriosus Stent System. The main goal is to see if this stent is safe and effective for patients who need their ductus arteriosus to remain open, which is a critical condition in some heart patients, particularly infants with certain congenital heart defects. The researchers are gathering data to potentially gain approval from the Food and Drug Administration (FDA), which would help make this treatment more widely available and improve care for those with this specific medical need. Participants in the study will receive the Lifeline Ductus Arteriosus Stent as part of their treatment. This stent is a small device that is placed in the ductus arteriosus to keep it open. The study will monitor how well the stent works and any side effects that occur. Although the study does not explicitly mention risks or benefits, typically, such studies aim to ensure that the device is both effective in its function and safe for patients to use.

Official TitleStarlight Cardiovascular Lifeline Ductus Arteriosus Stent IDE Study
NCT07114718
Principal SponsorStarlight Cardiovascular Inc
Study ContactMary Beth Tate, BSBE-MBA
Last updated: January 28, 2026
Sourced from a government-validated database.Claim as a partner

Protocol

This section provides details of the study plan, including how the study is designed and what the study is measuring.
Design Details

35 patients to be enrolled

Total number of participants that the clinical trial aims to recruit.

Treatment Study

These studies test new ways to treat a disease, condition, or health issue. The goal is to see if a new drug, therapy, or approach works better or has fewer side effects than existing options.



Eligibility

Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.
Conditions
Criteria

Any sex

Biological sex of participants that are eligible to enroll.

Until 6 Months

Range of ages for which participants are eligible to join.

Healthy volunteers not allowed

If individuals who are healthy and do not have the condition being studied can participate.

Conditions

Pathology

Congenital AbnormalitiesCardiovascular DiseasesHeart Defects, CongenitalHeart DiseasesCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesCardiovascular Abnormalities

Criteria

4 inclusion criteria required to participate
Parental or legal authorized representative provide consent for study enrollment

Infants < 6 months of age

Diagnosis of congenital heart defect with ductal-dependent pulmonary circulation requiring infusion of prostaglandins

Requires ductus arteriosus stent diameters of 3.5mm or 4mm and stent lengths between 16mm and 28mm

20 exclusion criteria prevent from participating
Active blood stream infection

Active or history of endocarditis

Body weight <2.5kg

Gestational age <32 weeks at birth

Show More Criteria

Study Plan

Find out more about all the medication administered in this study, their detailed description and what they involve.
Treatment Groups
Study Objectives

One single intervention group is designated in this study

This study does not include a placebo group 

Treatment Groups

Group I

Treatment with the Lifeline Ductus Arteriosus Stent

Study Objectives

Primary Objectives

Study Centers

These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.
This study has no location dataSave this study to your profile to know when the location data is available.
Recruiting soonNo study centers